BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Specialised Therapeutics Expands Incyte Partnership to Launch Axatilimab and Retifanlimab in Asia-Pacific

Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the expansion of its existing supply and distribution agree...

June 13, 2025 | News

Sweden’s Salipro Biotech Partners with South Korea’s Daewoong Pharmaceutical to Target Challenging Drug Discovery

- The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilize a challenging drug target and advance...

June 12, 2025 | News

Abbisko Therapeutics’ Pimicotinib NDA Accepted by China NMPA for Tenosynovial Giant Cell Tumor

Abbisko Therapeutics Co., Ltd. announced that the China National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) f...

June 11, 2025 | News

Innovent and HUTCHMED’s Sintilimab-Fruquintinib Combo Accepted for NMPA Review in Advanced Renal Cell Carcinoma

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

June 05, 2025 | News

Celltrion’s YUFLYMA® Wins Expanded Interchangeability Status for All Humira® Dosage Forms in the U.S.

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] Cellt...

May 26, 2025 | News

Cell Impact Secures Follow-Up Order for Test Tools from Leading Asian Industrial Player

Cell Impact AB (publ) has signed an agreement to deliver test tools to a leading industrial player in Asia. The deal confirms Cell Impact's attractive offe...

May 20, 2025 | News

AGC Biologics Partners with Quell Therapeutics to Advance Treg Cell Therapies for Immune Disorders

-AGC Biologics, your friendly CDMO expert, announced a partnership with Quell Therapeutics (“Quell”), a clinical-stage bio...

May 19, 2025 | News

Streamlining Biologics QC: How Waters’ Empower-MALS Integration Is Reshaping Analytical Workflows

Waters Corporation is tackling the complexity of biologics quality control with the integration of Multi-Angle Light Scattering (MALS) into its Empower&tr...

May 16, 2025 | Interaction

Dymax Expands TPO-Free Light-Curable Adhesive Line from Singapore to Support Global Compliance and Sustainability Goals

- Dymax, a leading manufacturer of rapid light-curing materials and equipment, responds to market interest in sustainable adhesive solutions and ...

May 14, 2025 | News

Leica Microsystems Launches Visoria Series to Streamline Routine Microscopy Across Life Science and Industry

Leica Microsystems, a leading provider of microscopy and scientific instrumentation, has launched the Visoria series of upright microscopes, to help enhanc...

May 08, 2025 | News

Waters Integrates MALS into Empower™ Software to Accelerate Biologics QC and Slash Validation Time

Saves up to six months on compliant software validation in biopharmaceutical quality control. Reduces analysis time for biotherapeutic peptides and prot...

May 07, 2025 | News

Genezen to Manufacture Lentiviral Vector for Optieum’s CAR-T Therapy Targeting Glioblastoma

Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Optieum Biotechnologies, Inc. (Optieum), a preclinical stag...

May 06, 2025 | News

Australia’s Viral Vector Manufacturing Facility Selects SYSPRO Cloud ERP to Drive Quality and Compliance in Biopharma Manufacturing

Viral Vector Manufacturing Facility Pty Ltd (VVMF) has selected SYSPRO for its Cloud ERP system. VVMF is Australia’s first viral...

April 29, 2025 | News

Primo Biotechnology Secures PIC/S GMP and GDP Certifications, Strengthening Global Position in Nuclear Medicine

Primo Biotechnology Co., Ltd. ("Primo") proudly announces that its Taoyuan pharmaceutical facility has successfully passed inspection by Taiwan Food and Dr...

April 25, 2025 | News

Stay Connected